image of a bearded man swimming shirtless in a frozen lake

Healing Thyself: The Future of Regenerative Medicine

A Conversation With Drew Taylor, CEO of Acorn Labs

Dr. Drew Taylor is a pioneer in the field of regenerative medicine. Convinced about the potential for regenerative medicine to prevent disease and slow aging, he launched a company that banks people’s stem cells, ensuring they’ll have access to higher quality cells for future regenerative applications. Taylor spoke with the president of Catalytic Health and publisher of Hypothesis, Rohit Khanna, about the the current state of regenerative and longevity medicine.

  • Drew Taylor

    holds a Ph.D. in Biomedical Engineering from the University of Toronto, an MSc from the University of Michigan in Molecular, Cellular, and Developmental Biology, was part of the Mount Sinai Hospital BioEngineering Skeletal Tissues Team, served as Chief Science Officer for Epic Capital Management, a health tech VC, and has also played professional baseball in the minor leagues within the Toronto Blue Jays and Philadelphia Phillies organizations.